Product
Recombinant Flt3 Ligand
1 clinical trial
9 indications
Indication
Breast Cancer, Stage IVIndication
Breast CancerIndication
Stage IV Breast Cancer AJCC v8Indication
Metastatic MelanomaIndication
melanomaIndication
Cutaneous Squamous Cell CarcinomaIndication
Merkel Cell CarcinomaIndication
Soft Tissue SarcomaIndication
Bone SarcomaClinical trial
A Phase I Study of In Situ Immunomodulation With CDX-301, Radiotherapy, CDX-1140, and Poly-ICLC in Patients With Unresectable and Metastatic Solid Tumors With Injectable Palpable DiseaseStatus: Recruiting, Estimated PCD: 2025-01-09